Clinical Trial Update: Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium [Phase 2]

View source ↗

Summary

Phase 2 trial assessing afamelanotide as adjunctive therapy to photodynamic therapy with porfimer sodium; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photodynamic Therapy Induced Conditions

Drugs mentioned

• Afamelanotide (afamelanotide)
• Porfimer Sodium (porfimer sodium)

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Patients Undergoing Photodynamic Therapy Using Porfimer Sodium | Phase 2 | Status: COMPLETED | Results posted: 2021-10-01